# Lazard, Inc.: financial statements, quarterly

LAZ · NYSE · CIK 1311370 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/laz.md) · [Financials](/companies/laz/financials.md) · [Filings](/companies/laz/filings.md) · [Insiders](/companies/laz/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/laz/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [826 d](/filings/0001311370-26-000008.md) | [785](/filings/0001628280-25-021162.md) | [708](/filings/0001311370-25-000022.md) | [807](/filings/0001311370-25-000052.md) | [839 d](/filings/0001311370-26-000008.md) | [669](/filings/0001311370-26-000015.md) | [817](/filings/0001311370-26-000022.md) | [771](/filings/0001311370-26-000027.md) | [929 d](/filings/0001311370-26-000008.md) | [779](/filings/0001311370-26-000015.md) | [830](/filings/0001311370-26-000022.md) | [836](/filings/0001311370-26-000027.md) |
| Operating income | $m | [71.9 d](/filings/0001311370-26-000008.md) | [54.6](/filings/0001628280-25-021162.md) | [63.6](/filings/0001311370-25-000022.md) | [161](/filings/0001311370-25-000052.md) | [107 d](/filings/0001311370-26-000008.md) | [54.6](/filings/0001311370-26-000015.md) | [93.1](/filings/0001311370-26-000022.md) | [94.9](/filings/0001311370-26-000027.md) | [85.0 d](/filings/0001311370-26-000008.md) | [89.6](/filings/0001311370-26-000015.md) | [37.6](/filings/0001311370-26-000022.md) | [54.8](/filings/0001311370-26-000027.md) |
| Interest expense | $m | [19.7 d](/filings/0001628280-25-007441.md) | [20.7](/filings/0001628280-24-018661.md) | [22.6](/filings/0001628280-24-033170.md) | [22.5](/filings/0001311370-25-000052.md) | [22.3 d](/filings/0001628280-25-007441.md) | [21.0](/filings/0001311370-26-000015.md) | [21.1](/filings/0001311370-26-000022.md) | [22.6](/filings/0001311370-26-000027.md) | [22.6 d](/filings/0001311370-26-000008.md) | [22.7](/filings/0001311370-26-000015.md) | [22.4](/filings/0001311370-26-000022.md) | [22.0](/filings/0001311370-26-000027.md) |
| Income tax | $m | [0.4 d](/filings/0001311370-26-000008.md) | [14.3](/filings/0001628280-25-021162.md) | [11.6](/filings/0001311370-25-000022.md) | [45.1](/filings/0001311370-25-000052.md) | [28.8 d](/filings/0001311370-26-000008.md) | [(7.4)](/filings/0001311370-26-000015.md) | [31.8](/filings/0001311370-26-000022.md) | [21.4](/filings/0001311370-26-000027.md) | [30.7 d](/filings/0001311370-26-000008.md) | [(11.0)](/filings/0001311370-26-000015.md) | [23.9](/filings/0001311370-26-000022.md) | [25.1](/filings/0001311370-26-000027.md) |
| Net income | $m | [63.6 d](/filings/0001311370-26-000008.md) | [35.8](/filings/0001628280-25-021162.md) | [49.9](/filings/0001311370-25-000022.md) | [108](/filings/0001311370-25-000052.md) | [86.3 d](/filings/0001311370-26-000008.md) | [60.4](/filings/0001311370-26-000015.md) | [55.3](/filings/0001311370-26-000022.md) | [71.2](/filings/0001311370-26-000027.md) | [49.9 d](/filings/0001311370-26-000008.md) | [101](/filings/0001311370-26-000015.md) | [4.8](/filings/0001311370-26-000022.md) | [29.2](/filings/0001311370-26-000027.md) |
| Diluted EPS | $ per share | not reported | [0.35](/filings/0001628280-25-021162.md) | [0.49](/filings/0001311370-25-000022.md) | [1.02](/filings/0001311370-25-000052.md) | not reported | [0.56](/filings/0001311370-26-000015.md) | [0.52](/filings/0001311370-26-000022.md) | [0.65](/filings/0001311370-26-000027.md) | not reported | [0.91](/filings/0001311370-26-000015.md) | [0.03](/filings/0001311370-26-000022.md) | [0.26](/filings/0001311370-26-000027.md) |
| Basic EPS | $ per share | not reported | [0.38](/filings/0001628280-25-021162.md) | [0.53](/filings/0001311370-25-000022.md) | [1.13](/filings/0001311370-25-000052.md) | not reported | [0.61](/filings/0001311370-26-000015.md) | [0.56](/filings/0001311370-26-000022.md) | [0.71](/filings/0001311370-26-000027.md) | not reported | [0.98](/filings/0001311370-26-000015.md) | [0.03](/filings/0001311370-26-000022.md) | [0.27](/filings/0001311370-26-000027.md) |

- Revenue: us-gaap:Revenues
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [971](/filings/0001311370-26-000008.md) | [923](/filings/0001628280-24-018661.md) | [848](/filings/0001628280-24-033170.md) | [1,166](/filings/0001628280-24-044770.md) | [1,308](/filings/0001311370-26-000008.md) | [909](/filings/0001628280-25-021162.md) | [978](/filings/0001311370-25-000022.md) | [1,172](/filings/0001311370-25-000052.md) | [1,469](/filings/0001311370-26-000027.md) | [1,021](/filings/0001311370-26-000015.md) | [1,100](/filings/0001311370-26-000022.md) | [1,264](/filings/0001311370-26-000027.md) |
| Total assets | $m | [4,636](/filings/0001628280-25-007441.md) | [4,587](/filings/0001628280-24-018661.md) | [4,527](/filings/0001628280-24-033170.md) | [4,820](/filings/0001628280-24-044770.md) | [4,794](/filings/0001311370-26-000008.md) | [4,232](/filings/0001628280-25-021162.md) | [4,493](/filings/0001311370-25-000022.md) | [4,634](/filings/0001311370-25-000052.md) | [4,936](/filings/0001311370-26-000027.md) | [4,241](/filings/0001311370-26-000015.md) | [4,365](/filings/0001311370-26-000022.md) | [4,548](/filings/0001311370-26-000027.md) |
| Total liabilities | $m | [4,066](/filings/0001628280-25-007441.md) | [4,050](/filings/0001628280-24-018661.md) | [3,932](/filings/0001628280-24-033170.md) | [4,056](/filings/0001628280-24-044770.md) | [4,029](/filings/0001311370-26-000008.md) | [3,500](/filings/0001628280-25-021162.md) | [3,623](/filings/0001311370-25-000022.md) | [3,677](/filings/0001311370-25-000052.md) | [3,952](/filings/0001311370-26-000027.md) | [3,287](/filings/0001311370-26-000015.md) | [3,349](/filings/0001311370-26-000022.md) | [3,498](/filings/0001311370-26-000027.md) |
| Long-term debt | $m | [1,690](/filings/0001628280-25-007441.md) | [1,851](/filings/0001628280-24-018661.md) | [1,852](/filings/0001628280-24-033170.md) | [1,853](/filings/0001628280-24-044770.md) | [1,687](/filings/0001311370-26-000008.md) | [1,688](/filings/0001628280-25-021162.md) | [1,689](/filings/0001311370-25-000022.md) | [1,687](/filings/0001311370-25-000052.md) | [1,688](/filings/0001311370-26-000027.md) | [1,689](/filings/0001311370-26-000015.md) | [1,690](/filings/0001311370-26-000022.md) | [1,690](/filings/0001311370-26-000027.md) |
| Shareholders' equity | $m | [424](/filings/0001628280-25-007441.md) | [393](/filings/0001628280-24-018661.md) | [459](/filings/0001628280-24-033170.md) | [624](/filings/0001628280-24-044770.md) | [636](/filings/0001311370-26-000008.md) | [603](/filings/0001628280-25-021162.md) | [742](/filings/0001311370-25-000022.md) | [842](/filings/0001311370-25-000052.md) | [869](/filings/0001311370-26-000027.md) | [881](/filings/0001311370-26-000015.md) | [914](/filings/0001311370-26-000022.md) | [949](/filings/0001311370-26-000027.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [342 d](/filings/0001311370-26-000008.md) | [(90.0)](/filings/0001628280-25-021162.md) | [176 d](/filings/0001311370-25-000022.md) | [294 d](/filings/0001311370-25-000052.md) | [363 d](/filings/0001311370-26-000008.md) | [(218)](/filings/0001311370-26-000015.md) | [49.7 d](/filings/0001311370-26-000022.md) | [287 d](/filings/0001311370-26-000027.md) | [400 d](/filings/0001311370-26-000008.md) | [(219)](/filings/0001311370-26-000015.md) | [203 d](/filings/0001311370-26-000022.md) | [316 d](/filings/0001311370-26-000027.md) |
| Capital expenditure | $m | [8.8 d](/filings/0001311370-26-000008.md) | [6.6](/filings/0001628280-25-021162.md) | [6.4 d](/filings/0001311370-25-000022.md) | [17.6 d](/filings/0001311370-25-000052.md) | [14.9 d](/filings/0001311370-26-000008.md) | [13.8](/filings/0001311370-26-000015.md) | [11.7 d](/filings/0001311370-26-000022.md) | [2.9 d](/filings/0001311370-26-000027.md) | [3.6 d](/filings/0001311370-26-000008.md) | [2.2](/filings/0001311370-26-000015.md) | [3.9 d](/filings/0001311370-26-000022.md) | [5.6 d](/filings/0001311370-26-000027.md) |
| Dividends paid | $m | [43.7 d](/filings/0001311370-26-000008.md) | [43.7](/filings/0001628280-25-021162.md) | [45.0 d](/filings/0001311370-25-000022.md) | [45.1 d](/filings/0001311370-25-000052.md) | [45.2 d](/filings/0001311370-26-000008.md) | [45.0](/filings/0001311370-26-000015.md) | [47.1 d](/filings/0001311370-26-000022.md) | [47.2 d](/filings/0001311370-26-000027.md) | [47.4 d](/filings/0001311370-26-000008.md) | [47.0](/filings/0001311370-26-000015.md) | [49.3 d](/filings/0001311370-26-000022.md) | [48.7 d](/filings/0001311370-26-000027.md) |
| Share repurchases | $m | [0.0 d](/filings/0001311370-26-000008.md) | [22.0](/filings/0001628280-25-021162.md) | [18.8 d](/filings/0001311370-25-000022.md) | [3.1 d](/filings/0001311370-25-000052.md) | [15.6 d](/filings/0001311370-26-000008.md) | [36.2](/filings/0001311370-26-000015.md) | [3.8 d](/filings/0001311370-26-000022.md) | [1.1 d](/filings/0001311370-26-000027.md) | [50.0 d](/filings/0001311370-26-000008.md) | [1.7](/filings/0001311370-26-000015.md) | [50.0 d](/filings/0001311370-26-000022.md) | [33.3 d](/filings/0001311370-26-000027.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [87.6](/filings/0001628280-24-018661.md) | [88.7](/filings/0001628280-24-033170.md) | [94.3](/filings/0001628280-24-044770.md) | [99.4](/filings/0001628280-25-021162.md) | [101](/filings/0001311370-25-000022.md) | [103](/filings/0001311370-25-000052.md) | [105](/filings/0001311370-26-000015.md) | [105](/filings/0001311370-26-000022.md) | [108](/filings/0001311370-26-000027.md) | [107](/filings/0001311370-26-000015.md) | [107](/filings/0001311370-26-000022.md) | [107](/filings/0001311370-26-000027.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 109,783,028 at 2026-10-16, from the cover of the [10-Q filed 2026-10-26](/filings/0001311370-26-000027.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 26, 2026, 16:54 ET. No prices; not investment advice.